Author: OurCrowd

[Glilot Capital in Globes] Glilot Capital sees handsome returns on startup investments

Sep 2, 2025 |

Israeli venture capital fund Glilot Capital Partners was founded by Arik Kleinstein and Kobi Samboursky to invest in cybersecurity and software companies. Glilot is not so well known or talked about in the industry like Gili Raanan’s Cyberstarts, which invested in Wiz, which was sold to Google earlier this year for $32 billion as well as Cyera and Talon, and Team8, which was founded by senior figures like Nadav Zafrir and Liran Greenberg. Read...

Read More

[Axiom Space in WebProNews] Axiom Space, Red Hat launch orbital data center for AI on ISS

Sep 2, 2025 |

In a groundbreaking push to extend computing frontiers beyond Earth’s atmosphere, a prototype orbital data center has been launched to the International Space Station (ISS), orbiting approximately 400 kilometers above the planet. This initiative, spearheaded by Axiom Space in collaboration with Red Hat and sponsored by the ISS National Laboratory, aims to test the viability of edge computing in the harsh environment of space. Delivered via a SpaceX mission in August 2025, the compact system represents a pivotal step toward enabling real-time data processing for future space exploration, where latency from Earth-based servers could hinder critical operations. Read...

Read More

[Anthropic in Anthropic] Anthropic raises $13B Series F at $183B post-money valuation

Sep 2, 2025 |

Anthropic has completed a Series F fundraising of $13 billion led by ICONIQ. This financing values Anthropic at $183 billion post-money. Along with ICONIQ, the round was co-led by Fidelity Management & Research Company and Lightspeed Venture Partners. The investment reflects Anthropic’s continued momentum and reinforces our position as the leading intelligence platform for enterprises, developers, and power users. Read...

Read More

[Alpha Tau in Globe Newswire] Alpha Tau successfully treats first patient in its U.S. multi-center pancreatic cancer clinical trial

Sep 2, 2025 |

JERUSALEM, Sept. 02, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® today announced that the first patient has been treated in its U.S. multi-center pancreatic cancer pilot study, known as IMPACT (Intratumoral Pancreatic Alpha Combination Trial), evaluating the safety, feasibility, and efficacy of Alpha DaRT in combination with chemotherapy for patients with newly diagnosed unresectable locally advanced or metastatic pancreatic adenocarcinoma. Read...

Read More

[CropX in PR Newswire] CropX acquires Acclym (formerly Agritask) to power enterprise-scale sustainable food systems

Sep 2, 2025 |

TEL-AVIV, Israel, Sept. 2, 2025 /PRNewswire/ — CropX Technologies, a global leader in digital agronomic solutions, announced today its acquisition of Acclym (formerly Agritask), an enterprise-grade agricultural intelligence company with a 15-year track record of enabling top food and beverage brands to deliver on their agricultural sustainability commitments. This marks the seventh strategic acquisition by CropX, following its 2024 acquisition of nitrogen sensor innovator EnGeniousAg and 2023 acquisition of Australia’s Green Brain. Read...

Read More